We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$119M
AUM Growth
+$3.11M
Cap. Flow
+$619K
Cap. Flow %
0.52%
Top 10 Hldgs %
22.99%
Holding
184
New
25
Increased
49
Reduced
67
Closed
21

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.48M
2
ADI icon
Analog Devices
ADI
+$1.13M
3
PRXL
Parexel International Corp
PRXL
+$1.1M
4
MSFT icon
Microsoft
MSFT
+$969K
5
JWN
Nordstrom
JWN
+$833K

Sector Composition

Rank Sector Weight
1 Industrials 18.45%
2 Healthcare 16.9%
3 Consumer Staples 13.84%
4 Financials 13.02%
5 Consumer Discretionary 11.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTNT icon
101
Fortinet
FTNT
$117B
$407K 0.34%
55,125
-23,000
-29% -$161K
ALK icon
102
Alaska Air
ALK
$5.58B
$403K 0.34%
6,125
NSC icon
103
Norfolk Southern
NSC
$75.1B
$393K 0.33%
4,050
-850
-17% -$77.4K
QSR icon
104
Restaurant Brands International
QSR
$25.8B
$391K 0.33%
8,761
MDLZ icon
105
Mondelez International
MDLZ
$79.9B
$387K 0.32%
+8,810
New +$387K
HD icon
106
Home Depot
HD
$355B
$383K 0.32%
2,973
-450
-13% -$60K
VTRS icon
107
Viatris
VTRS
$18.9B
$379K 0.32%
9,950
-200
-2% -$8.89K
BDC icon
108
Belden
BDC
$5.19B
$373K 0.31%
5,400
-725
-12% -$50.4K
WPC icon
109
W.P. Carey
WPC
$16.4B
$367K 0.31%
5,803
-817
-12% -$54.5K
WFM
110
DELISTED
Whole Foods Market Inc
WFM
$364K 0.31%
+12,836
New +$395K
REGN icon
111
Regeneron Pharmaceuticals
REGN
$80.8B
$344K 0.29%
855
-290
-25% -$116K
GM icon
112
General Motors
GM
$76.8B
$340K 0.29%
+10,695
New +$334K
WHR icon
113
Whirlpool
WHR
$2.82B
$336K 0.28%
2,075
-250
-11% -$44.3K
SAVE
114
DELISTED
Spirit Airlines, Inc.
SAVE
$335K 0.28%
7,875
-500
-6% -$20.7K
AMSG
115
DELISTED
Amsurg Corp
AMSG
$322K 0.27%
+4,800
New +$335K
WKC icon
116
World Kinect Corp
WKC
$1.86B
$319K 0.27%
6,900
+1,000
+17% +$46.1K
PRXL
117
DELISTED
Parexel International Corp
PRXL
$319K 0.27%
4,600
-16,311
-78% -$1.1M
BBWI icon
118
Bath & Body Works
BBWI
$4.1B
$315K 0.26%
5,505
-2,226
-29% -$131K
KMI icon
119
Kinder Morgan
KMI
$68.7B
$313K 0.26%
13,538
-5,204
-28% -$110K
WBA
120
DELISTED
Walgreens Boots Alliance
WBA
$312K 0.26%
3,875
-200
-5% -$16.3K
CFC.PRB.CL
121
DELISTED
Countrywide Capital V
CFC.PRB.CL
$309K 0.26%
+12,000
New +$309K
CYNO
122
DELISTED
Cynosure, Inc. Class A
CYNO
$309K 0.26%
+6,075
New +$315K
STT.PRC.CL
123
DELISTED
STATE STREET CORPORATION Depositary Shares, each representing a 1/4,000th ownership interest in a sh
STT.PRC.CL
$303K 0.25%
11,900
BNS icon
124
Scotiabank
BNS
$108B
$298K 0.25%
5,625
OI icon
125
O-I Glass
OI
$1.08B
$298K 0.25%
16,200
-500
-3% -$9.07K

Similar funds

New England Research & Management's Q3 2016 Portfolio in Review

As of Q3 2016, New England Research & Management held 184 positions worth $119M, up 2.7% from $116M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

New England Research & Management's Q3 2016 filing shows 25 new, 49 increased, 67 reduced and 21 closed positions. Its largest new stake was Installed Building Products: 19,900 shares worth $714K. The largest sale was Merck, an estimated $1.48M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Staples.

  • New England Research & Management's largest Q3 2016 buy was Installed Building Products: 19,900 shares worth $714K.
  • New England Research & Management added most to Bristol-Myers Squibb in Q3 2016, an estimated $881K increase.
  • New England Research & Management's biggest Q3 2016 reduction was Merck, cutting an estimated $1.48M.
  • New England Research & Management fully exited Analog Devices in Q3 2016, selling an estimated $1.13M.
  • New England Research & Management's ten largest holdings make up 23% of its $119M portfolio in Q3 2016.
  • New England Research & Management opened 25 new positions and closed 21 in Q3 2016.
  • New England Research & Management's portfolio value rose 2.7% quarter-over-quarter to $119M.

Based on New England Research & Management's 13F filing for Q3 2016, filed 5 Oct 2016.